Enhanced Development of Human Innate Immunity in Humanized Mice
Learn about JAX's enhanced innate immune models: the CD34+ engrafted NSG-FLT3 and NSG-FLT3-IL15 mice, presented by Michael Brehm, Ph.D., UMass Medical School.
Watch Video
Immuno-Oncology/Oncology
-
-
Comparing Immunodeficient Models for Cancer, Immunity, and Transplant Research
During this webinar, we will discuss the most widely used immunodeficient mouse models and important considerations for selecting the most appropriate model.
Watch Video
-
JAX Humanized Mice PubCast: Acute Myeloid Leukemia + NSG-MHC I/II DKO Mice
In this episode, we delve into a publication that established a novel humanized mouse model of graft-versus-leukemia that better recapitulates the characteristics of AML relapse seen in patients.
Watch Video
-
Loading, please wait
Error - something went wrong!
Don't miss new content. Subscribe to our monthly newsletter, JAX Pulse!
Thank you!
-
Comparing Immune-Humanized Mouse Platforms for Preclinical Applications
During this presentation, we will compare strategies for immune humanization of NSG variants to support translatable preclinical immunology, and oncology research. researchers a powerful tool for cha
Watch Video
-
NSG-FLT3-IL15: A More Comprehensive Immune Humanized Model for Natural Killer Cells
In this presentation, we introduce The Jackson Laboratory’s most comprehensive immune humanized mouse platform to date: NSG- FLT3-IL15.
Watch Video
-
Cancer immunotherapy: getting a little help from ourselves
We review strategies and mouse models used to develop highly promising therapeutic treatments using the body’s own immune system in the fight against cancer.
Learn More
-
New Immune-humanized Models Support More Diverse Human Immune Cell Lineages
In this webinar, we will introduce two new enhanced NSG models developed at The Jackson Laboratory: NSG-SGM3-IL15 and NSG-FLT3.
Watch Video
-
The Promise of Cancer Genomics
Learn about the advantages of using genomic-based strategies in the fight against cancer
Learn More
-
Exploring Cancer Research: Tools and Technologies
Find out which tools and technologies are used by scientists to advance the field of cancer research, including sequencing, cell-based models of cancer, and mouse models of cancer.
Learn More
-
Leveraging Gene Therapy to Achieve Long-Term Continuous or Controllable Expression of Biotherapeutics
Leading this presentation is guest speaker Dr. Timothy Cripe from Nationwide Children’s Hospital and The Ohio State University.
Watch Video
-
A Novel In Vivo Model to Simultaneously Assess Efficacy and Toxicity of Chimeric Antigen Receptor T-Cell Immunotherapy
Read Flipbook
-
Exploring Cancer: Biology and Inheritance
Discover the fundamental properties of cancer cells and explore the genetic basis, inheritance, risk factors and prevention of this disease.
Learn More
-
Immune-Humanized PDX Model-Estrogen-Independent, Hormone Receptor-Positive Metastatic Breast Cancer
The most common type of breast cancer is estrogen receptor-positive (ER+). ER+ tumors can be successfully treated with hormone therapy, but many tumors acquire endocrine resistance which limits treatm
Watch Video
-
Predictive Pre Clinical Oncology Studies Using Patient-Derived Xenograft Platforms
This on-demand webinar provides strategies for using PDX models in predictive preclinical research and an introduction to PDX models for immuno-oncology research.
Watch Video
-
How To Make Your New NSG Variant in a Fraction of the Time
CRISPR/Cas9 can quickly generate new translational mouse models directly on the genetic background needed for your preclinical research. This saves valuable research time by reducing the need for...
Learn More
-
Achieving Relevant Preclinical Characterization of CAR T Cell Therapies
This whitepaper examines the constraints and challenges inherent in each CAR T study type and how to overcome them with in vivo studies using fully humanized mouse models.
Read Flipbook
-
Designing Your In Vivo Studies
September 9, 2021 - Learn about unique experimental design considerations and critically important topics that affect the reproducibility of your In Vivo research studies.
Watch Video
-
JAX Tech Talk Episode 48: Developing Immunotherapies with Hu-NSG-MHC I/II DKO Mice (Jan. 11, 2022)
January 11, 2022 - In this episode, we will discuss using PBMC humanized NSG-MHC I/II DKO mice in preclinical research to develop and assess efficacy of human immuno-therapeutics.
Watch Video
-
Introduction to In Vivo Platforms for Cancer Immunotherapy
Grace Berryhill, Ph.D. provides an overview of in vivo platforms being used to improve the translational relevance of cancer immunotherapies.
Watch Video
-
Human KIT+ Myeloid Cells Facilitate Visceral Metastasis By Melanoma
Chun Yu, Ph.D., Associate Research Scientist at The Jackson Laboratory speaks about Human KIT+ myeloid cells and how they facilitate visceral metastasis by melanoma.
Watch Video
-
Loading More...
